Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid
Ronald M. Bukowski(Cleveland Clinic), Robert F. Peterson(Cancer Research And Biostatistics), Catherine M. Tangen(American Urological Association), Saul E. Rivkin(University of Puget Sound), Thomas R. Fleming(University of Washington), John S. Macdonald(Salford Royal NHS Foundation Trust), John J. Rinehart(Memorial Sloan Kettering Cancer Center), Sarah A. Taylor(Baylor Scott & White Medical Center - Temple), Harmon J. Eyre(American Cancer Society)
Cited by 89
Related Papers
Frailty in Older Adults: Evidence for a Phenotype
|The Journals of Gerontology Series A|2001|24.4k
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
|New England Journal of Medicine|2003|2.6k
American Cancer Society Guidelines for the Early Detection of Cancer
|CA A Cancer Journal for Clinicians|2002|1.6k
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
|Circulation|2004|1.2k